Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics. Bennett WM, Muther RS, Parker RA, Feig P, Morrison G, Golper TA, Singer I (1980) Ann Intern Med 93: 62-89 Accidents with Tenckhoff catheters. Golper TA, Carpenter J (1981) Ann Intern Med 95: 121-2 Incremental dialysis. Golper TA (1998) J Am Soc Nephrol 9: S107-11 Continuous ambulatory peritoneal dialysis--quo vadis? Teehan BP, Hakim R (1995) J Am Soc Nephrol 6: 139-43 Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Bunke CM, Brier ME, Golper TA (1997) Kidney Int 52: 524-9 Peritoneal catheter obstruction by sigmoid colon wall. Motonishi S, Shuta M, Ishibashi Y, Yoshitaka I, Kawarazaki H, Hiroo K, Katagiri D, Daisuke K, Hirata Y, Yugo H, Kume H, Haruki K, Fujita T, Toshiro F (2011) Kidney Int 79: 1032 Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I (1991) Kidney Int 40: 461-9 Short-term effects of recombinant human growth hormone in CAPD patients. Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM (1994) Kidney Int 46: 1178-83 Achieving more frequent and longer dialysis for the majority: wearable dialysis and implantable artificial kidney devices. Fissell WH, Roy S, Davenport A (2013) Kidney Int 84: 256-64 Learning about the practice of peritoneal dialysis. Golper TA (2009) Kidney Int 76: 12-4 Nutrition in end-stage renal disease. Ikizler TA, Hakim RM (1996) Kidney Int 50: 343-57 Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients. Ikizler TA, Wingard RL, Flakoll PJ, Schulman G, Parker RA, Hakim RM (1996) Kidney Int 50: 229-34 Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies. Marx MA, Shuler CL, Tattersall JE, Golper TA (1995) Kidney Int 48: 1994-7 Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients. Leone MR, Jenkins RD, Golper TA, Alexander SR (1986) Crit Care Med 14: 1058-63 Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Pulliam JP, Vernon DD, Alexander SR, Hartstein AI, Golper TA (1983) Am J Kidney Dis 2: 610-4 Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review. Bieber SD, Burkart J, Golper TA, Teitelbaum I, Mehrotra R (2014) Am J Kidney Dis 63: 1027-37 Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A (2011) Am J Kidney Dis 58: 879-85 Renal replacement therapies in the elderly: Part 1. Hemodialysis and chronic peritoneal dialysis. Ismail N, Hakim RM, Oreopoulos DG, Patrikarea A (1993) Am J Kidney Dis 22: 759-82 Report of workshop on technique and technology. Hakim RM, Nissenson AR (1993) Am J Kidney Dis 21: 109-10 First-year outcomes of incident peritoneal dialysis patients in the United States. Pulliam J, Li NC, Maddux F, Hakim R, Finkelstein FO, Lacson E (2014) Am J Kidney Dis 64: 761-9 Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW, Strife F, Hamburger RJ (1996) Am J Kidney Dis 28: 428-36 Diagnosis of lymphoma in a continuous ambulatory peritoneal dialysis patient by peritoneal fluid cytology. Bargman JM, Zent R, Ellis P, Auger M, Wilson S (1994) Am J Kidney Dis 23: 747-50 Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin. Sewell DL, Golper TA, Brown SD, Nelson E, Knower M, Kimbrough RC (1983) Am J Kidney Dis 3: 209-12 Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Steinberg EP, Eknoyan G, Levin NW, Eschbach JW, Golper TA, Owen WF, Schwab S (2000) Am J Kidney Dis 36: 1-11 Analysis of the causative pathogens in uncomplicated CAPD-associated peritonitis: duration of therapy, relapses, and prognosis. Golper TA, Hartstein AI (1986) Am J Kidney Dis 7: 141-5 Dialysis modality distribution in the United States. Mendelssohn DC, Blake PG, Burkart J, Golper T, Oreopoulous D (2001) Am J Kidney Dis 37: 1330-1 Morbidity and mortality in redefining adequacy of peritoneal dialysis: a step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative. Chatoth DK, Golper TA, Gokal R (1999) Am J Kidney Dis 33: 617-32 Accuracy of patients' reports of comorbid disease and their association with mortality in ESRD. Cavanaugh KL, Merkin SS, Plantinga LC, Fink NE, Sadler JH, Powe NR (2008) Am J Kidney Dis 52: 118-27 Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study. Bunke M, Brier ME, Golper TA (1995) Am J Kidney Dis 25: 769-74 Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Ikizler TA, Wingard RL, Hakim RM (1995) Am J Kidney Dis 26: 256-65 Dancing around elephants. Golper TA (2013) Clin J Am Soc Nephrol 8: 1643-4 Individual quality of life in chronic kidney disease: influence of age and dialysis modality. Abdel-Kader K, Myaskovsky L, Karpov I, Shah J, Hess R, Dew MA, Unruh M (2009) Clin J Am Soc Nephrol 4: 711-8 Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Isakova T, Xie H, Barchi-Chung A, Vargas G, Sowden N, Houston J, Wahl P, Lundquist A, Epstein M, Smith K, Contreras G, Ortega L, Lenz O, Briones P, Egbert P, Ikizler TA, Jueppner H, Wolf M (2011) Clin J Am Soc Nephrol 6: 2688-95 Early outcomes among those initiating chronic dialysis in the United States. Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM (2011) Clin J Am Soc Nephrol 6: 2642-9 Nephrology quiz and questionnaire: renal replacement therapy. Golper TA, Discussant, Glassock RJ, Bleyer AJ (2012) Clin J Am Soc Nephrol 7: 1347-52 Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Golper TA, Hartstein AI, Morthland VH, Christensen JM (1987) Antimicrob Agents Chemother 31: 1787-90
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.